Staphylococcus aureus resistant to vancomycin--United States, 2002.
about
Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremiaTelavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureusCommunity-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemicReduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsDalbavancin in the treatment of complicated skin and soft-tissue infections: a reviewActivity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolidAntimicrobial resistance: the example of Staphylococcus aureusLysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat modelMethicillin-resistant Staphylococcus aureus (MRSA) in rehabilitation and chronic-care-facilities: what is the best strategy?Investigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospitalCloxacillin versus vancomycin for presumed late-onset sepsis in the Neonatal Intensive Care Unit and the impact upon outcome of coagulase negative staphylococcal bacteremia: a retrospective cohort study.Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infectionsReview of vancomycin-induced renal toxicity: an updateInfection prevention and the medical director: uncharted territoryPotential role of tedizolid phosphate in the treatment of acute bacterial skin infectionsBacterial endophthalmitis in the age of outpatient intravitreal therapies and cataract surgeries: host-microbe interactions in intraocular infectionAcquired inducible antimicrobial resistance in Gram-positive bacteriaGuidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspectiveAdvocacy, promotion and e-learning: Supercourse for zoonosisIdentification and characterization of sigma, a novel component of the Staphylococcus aureus stress and virulence responsesEfficient photodynamic therapy against gram-positive and gram-negative bacteria using THPTS, a cationic photosensitizer excited by infrared wavelengthVancomycin activates σ(B) in vancomycin-resistant Staphylococcus aureus resulting in the enhancement of cytotoxicityNovel bacterial metabolite merochlorin A demonstrates in vitro activity against multi-drug resistant methicillin-resistant Staphylococcus aureusElucidation of the Mode of Action of a New Antibacterial Compound Active against Staphylococcus aureus and Pseudomonas aeruginosaResistance Mechanisms, Epidemiology, and Approaches to Screening for Vancomycin-Resistant Enterococcus in the Health Care SettingCoagulase-negative staphylococci.Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literatureRapid detection of antimicrobial-resistant organism carriage: an unmet clinical needSystemic antibacterial activity of novel synthetic cyclic peptides.Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.Development of improved inhibitors of wall teichoic acid biosynthesis with potent activity against Staphylococcus aureus.Comparison of three PCR primer sets for identification of vanB gene carriage in feces and correlation with carriage of vancomycin-resistant enterococci: interference by vanB-containing anaerobic bacilli"Swimming in resistance": Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa.Photodynamic effects of novel XF porphyrin derivatives on prokaryotic and eukaryotic cells.Colonization and infection of the skin by S. aureus: immune system evasion and the response to cationic antimicrobial peptides.Systematic review of antibiograms: A National Laboratory System approach for improving antimicrobial susceptibility testing practices in Michigan.Identification of tigecycline- and vancomycin-resistant Staphylococcus aureus strains among patients with urinary tract infection in Iran.Comparative supragenomic analyses among the pathogens Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae using a modification of the finite supragenome modelIncreased neutrophil extracellular trap-mediated Staphylococcus aureus clearance through inhibition of nuclease activity by clindamycin and immunoglobulinReduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function
P2860
Q21261829-B339F45E-E9DB-436D-A409-AB14B1ECA349Q24556635-C7795449-F07D-48D8-BC83-A88001468520Q24614464-D9742FC9-0599-4D29-AE6A-33B49F959B02Q24646677-9613E761-0D92-44D8-A8BD-367B6B543A7BQ24647429-C5844DEA-E858-48B4-B287-C4923764B6DBQ24650535-51C8B5A3-7A16-46E7-8493-D11B7A144DF7Q24676363-457EB8CD-739F-4C6A-AA24-FAF95720ADC2Q24682172-F434141E-A925-4BD4-ADEB-A62E163ED647Q24805146-A8738CF2-90F4-46D7-AF37-AC315D6F4D0DQ24810927-277A73B7-AF24-4B15-83D1-40664C980B93Q25256319-A3E0A319-075B-4871-90EF-821C67B9BD32Q26746197-61183A1E-94F6-49AA-A3D7-6143450BFD92Q26746932-53FA2FEE-171C-4CC1-995D-000D85A7368AQ26825010-2BC8EE97-19DD-421C-99B9-EF6B95866A1FQ26853612-7F904A34-9A5E-4AD7-A9B6-DA5689D6CBD5Q26998053-DAB79641-69EB-477D-AEFB-195D4EE931D4Q27027012-7AF8BE7C-A195-4AB2-A702-3108F2A231CDQ28388806-3FF08523-E2FD-4CC4-B823-4F3DC9AA753EQ28390170-0F4E6C57-A233-4D92-9CA1-A5B45D3A2012Q28474120-A11AF80D-16E9-440A-AA1B-83597DF6A316Q28474872-24EBC3DB-5281-4C34-A882-AA97A6D02601Q28476797-D312AD87-CB0C-496A-8B7C-8651A894EC45Q28478951-B15E637E-8F50-4AC5-A598-1D6DE66CBE07Q28551971-63BCC20B-D2FB-4018-8C09-A16DEFCE0B1CQ30251425-1B481636-FEDE-401B-ABD5-8874408B28E0Q30401758-7F2F3123-F6A2-4E09-814A-2903717559DAQ31109071-84F2B4DE-F40C-41C7-8604-0A9FB6F099EDQ33204570-CE2D3689-BECD-4327-A078-978EB659C552Q33220464-B0151AE5-FE49-4210-8948-E594D3481197Q33261667-708BFDF6-23D2-45CE-8BCE-10644AEB9779Q33529977-554EDC54-3B54-437F-8776-E3E2D6B48331Q33556179-3B101154-F12F-4C80-BB48-9E469EA830A0Q33648238-6D114EF0-E261-499B-9D61-49B2B0DEF64BQ33722039-D956F23F-6EC2-418C-B3D7-D1CF9E1F4115Q33755855-29457DA8-A272-4F1A-B2AB-5488C3B6FE18Q33758419-915DACC4-1843-4845-9F29-8D2935FB510AQ33822841-63777491-E998-4B26-B44F-E28198281182Q33871710-DEE938B6-8B85-4A55-8C6A-0882281D08EDQ33880228-7FA6A45D-82B3-4B7A-A797-6294BCB4AF0AQ33883752-7D0EFC50-C74A-4460-8C63-9881D3D6B8BF
P2860
Staphylococcus aureus resistant to vancomycin--United States, 2002.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Staphylococcus aureus resistant to vancomycin--United States, 2002.
@ast
Staphylococcus aureus resistant to vancomycin--United States, 2002.
@en
Staphylococcus aureus resistant to vancomycin--United States, 2002.
@nl
type
label
Staphylococcus aureus resistant to vancomycin--United States, 2002.
@ast
Staphylococcus aureus resistant to vancomycin--United States, 2002.
@en
Staphylococcus aureus resistant to vancomycin--United States, 2002.
@nl
prefLabel
Staphylococcus aureus resistant to vancomycin--United States, 2002.
@ast
Staphylococcus aureus resistant to vancomycin--United States, 2002.
@en
Staphylococcus aureus resistant to vancomycin--United States, 2002.
@nl
P1476
Staphylococcus aureus resistant to vancomycin--United States, 2002
@en
P304
P577
2002-07-01T00:00:00Z